AlphAIAlphAI — Financial news for AI agents
tradingview.com$SGRY

Surgery Partners 3Q 2026: Revenue $815.3M, EPS ($0.16) — 10-Q Summary

Surgery Partners reported 3Q 2026 revenue of $815.3M, down 0.8% YoY, and a net loss of $21.1M, improved 7% YoY. Same-facility revenue rose 6.0%, driven by higher revenue per case. The company completed the sale of Idaho hospitals in September 2026.

Original reporting
tradingview.com
Published Nov 9, 2026, 10:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Surgery Partners 3Q 2026: Revenue $815.3M, EPS ($0.16) — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$SGRYNeutralLow
01

Why it matters

The filing provides the first public numbers for the quarter, offering traders fresh data to reassess valuation.

02

Market read

Primary earnings disclosure for a mid‑cap healthcare operator; modest trading relevance.

03

What to watch

Same‑facility revenue growth of 6% suggests operational improvements despite overall revenue decline.

Relevance 7/10Novelty 6/10Timing: post‑market release

Background

Surgery Partners (SGRY) filed its Q3 2026 10‑Q, reporting a modest revenue decline and a narrowed net loss, alongside the sale of Idaho assets.

Company-level read

Ticker impact

$SGRYNeutralHigh confidence
Context

Q3 2026 10‑Q shows revenue $815.3M, EPS –$0.16 and a narrowed net loss, plus completion of the Idaho Transaction.

Expected impact

likely slight downside as investors digest a small revenue decline and loss narrowing

Evidence & confidence

The numbers are a fresh disclosure; revenue fell 0.8% YoY and loss narrowed, but the Idaho asset sale may offset concerns.

Market effects

Sector

Surgery Partners' results may signal modest pressure on the outpatient surgery sector.

Regional

Limited to U.S. healthcare investors.

Global

Low global relevance.

Counterpoint

What could challenge this read

The Idaho transaction could free capital for growth, offsetting the slight revenue dip.

Key entities

  • company
    Surgery Partners, Inc.

    Operator of outpatient surgery facilities.

Read at source← All news

StorySurgery Partners posts narrower Q3 loss and lifts merger price to $25 per share

Also covered by

3 outlets

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

local3news.com
$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re

SEC EDGAR 8-K
$SGRYHighAI 9/10

Why is Surgery Partners (SGRY) stock rocketing higher today

Surgery Partners (SGRY) stock rose 12% after amending its merger agreement with HealthSpan Partners, increasing the buyout offer to $25 per share and valuing the company at up to $6.0 billion. The board unanimously recommends shareholders approve the revised deal, which includes potential additional cash ticking fees. The stock has seen significant volatility, gaining 70.3% year-to-date and setting a new 52-week high.

financialcontent.com